Factors Restraining Growth of the Bronchodilator Industry The Global Bronchodilator Industry is on track for significant expansion, with a projected market value of US$67.8 billion by 2034. This steady growth trajectory signifies a Compound Annual Growth Rate (CAGR) of approximately 5.9% anticipated from 2024 to 2034. The current market size is estimated at US$38.2 billion in 2024, highlighting the increasing demand for these respiratory medications. Several factors are anticipated to spur growth in the bronchodilator industry. These include the rising prevalence of respiratory diseases such as asthma and COPD, the growing geriatric population, and increasing government initiatives and programs. The rising geriatric population globally is emerging as a key factor driving demand for bronchodilators. As age increases, people become more susceptible to lung problems. According to the journal Clinical Interventions in Ageing, the aging population is significantly impacted by pulmonary illness. Request a Sample of this Report Now! https://www.futuremarketinsights.com/reports/sample/rep-gb-18332